RALEIGH, NC--(Marketwire - September 14, 2010) -
| Highlighted Links |
|
INC Research ®, a therapeutically focused contract research organization (CRO) with a trusted process for delivering reliable results, has appointed three new medical directors to oversee the medical management teams in each region and enhance its high standard of scientific and medical support to global clinical trials. Dr. Claudia Trillo joins as medical director in Buenos Aires, Argentina, Dr. Rick Chen joins as associate medical director in Beijing, China, and Dr. Bhawana Awasthy joins as Senior Medical Director located in Gurgaon, Delhi, India.
“We are thrilled to expand our global Medical Management team with these esteemed physicians,” said Malcolm Fletcher, chief medical officer of INC Research. “By hiring very seasoned medical professionals who combine patient-care experience with trial-management expertise, our team is very good at understanding the investigator site environment. By immersing themselves into the safety and efficacy of a trial, they are able to make critical steering decisions that have a profound effect on the reliability of the results.”
Dr. Trillo in Buenos Aires has 14 years of industry experience in multiple indications. She started her industry career at Quintiles, followed by roles at Searle, GSK and Kendle. She trained in medicine at the Universidad de Buenos Aires, Medical School, and has board certification in Critical Care Medicine.
Dr. Chen in Beijing has more than 10 years of academic experience in ischemic stroke, cardiovascular disease and rheumatoid arthritis research. He is experienced in selecting and initiating investigate sites, providing training and performing routine site monitoring during the process of clinical trials, He has also contributed to furthering research education by publishing more than 10 papers in peer-reviewed journals.
Dr. Awasthy in Gurgaon brings 17 years of combined clinical-practice and clinical-research experience to INC Research. She is a proven leader both in Industry and among her medical colleagues, maintaining her specialization in oncology while designing, writing and implementing studies in Phase I through Phase IV on a global level.
INC Research’s Medical Management team is comprised of in-house physicians who provide round-the-clock medical monitoring services, as well as scientific and medical support for project management teams and investigative sites. The team has a diversity of backgrounds and specialties and covers the range from small proof-of-concept studies to large multinational pivotal studies with equal flexibility. To learn more about INC Research’s Medical Monitoring trial services, click here.
About INC Research® Inc.
INC Research is a therapeutically focused contract research organization (CRO) with a high performance reputation for conducting global clinical development programs of the highest integrity. Pharmaceutical and biotechnology companies look to INC Research for a complete range of customized Phase I through Phase IV programs in therapeutic areas of specialty, and in innovative pediatric and women’s health trials. The company’s The Trusted Process® methodology and therapeutic foresight leads customers to more confident, better-informed drug and device development decisions. INC Research is headquartered in Raleigh, North Carolina. For more information please visit www.incresearch.com.
Media contact:
Kelly Foster
Email Contact
+ 1 619-224-1261
Digg this
Bookmark with del.icio.us
Add to Newsvine
Technorati: 
